Centrient Pharmaceuticals (until December 2018 known as DSM Sinochem Pharmaceuticals) is the global leader in sustainable antibiotics, next-generation statins and anti-fungals. Centrient develops, produces and sells intermediates, active pharmaceutical ingredients and drug products. Our employees worldwide work together to deliver cutting-edge generics solutions that help to keep customers ahead of the competition. Headquartered in Rotterdam, Netherlands, the group has manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico. Centrient Pharmaceuticals is wholly owned by Bain Capital, a leading global investment firm.